Order Article Reprints

Patel G, Iskandar B, Chelikam N, Jain S, Vyas V, Singla T, Dondapati L, Bombaywala A, Peela AS, Khealani M, et al. Outcomes and Safety of Direct Oral Anticoagulants (DOACs) versus Vitamin K Antagonists (VKAs) amongst Patients with Valvular Heart Disease (VHD): A Systematic Review and Meta-Analysis. Hearts. 2023; 4(3):61-72. https://doi.org/10.3390/hearts4030008

Patel, Ghanshyam, Beshoy Iskandar, Nikhila Chelikam, Siddhant Jain, Vandit Vyas, Tanvi Singla, Lavanya Dondapati, Ali Bombaywala, Appala Suman Peela, Milan Khealani, and et al. 2023. "Outcomes and Safety of Direct Oral Anticoagulants (DOACs) versus Vitamin K Antagonists (VKAs) amongst Patients with Valvular Heart Disease (VHD): A Systematic Review and Meta-Analysis" Hearts 4, no. 3: 61-72. https://doi.org/10.3390/hearts4030008

Patel, G., Iskandar, B., Chelikam, N., Jain, S., Vyas, V., Singla, T., Dondapati, L., Bombaywala, A., Peela, A. S., Khealani, M., Mukesh, S., Korsapati, H. R., Korsapati, A. R., Regassa, H., Jain, N., Patel, U., & Venkata, V. S. (2023). Outcomes and Safety of Direct Oral Anticoagulants (DOACs) versus Vitamin K Antagonists (VKAs) amongst Patients with Valvular Heart Disease (VHD): A Systematic Review and Meta-Analysis. Hearts, 4(3), 61-72. https://doi.org/10.3390/hearts4030008